Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Clarissa A. Whitehead, Andrew H. Kaye, Katharine J. Drummond, Samuel S. Widodo, Theo Mantamadiotis, Laura J. Vella & Stanley S. Stylli. (2020) Extracellular vesicles and their role in glioblastoma. Critical Reviews in Clinical Laboratory Sciences 57:4, pages 227-252.
Read now
Read now
Tongxia Zhang, Jie Chai & Lingyi Chi. (2019) Induction Of XLF And 53BP1 Expression Is Associated With Temozolomide Resistance In Glioblastoma Cells. OncoTargets and Therapy 12, pages 10139-10151.
Read now
Read now
Yichun He, Jing Su, Beiwu Lan, Yufei Gao & Jingxia Zhao. (2019) Targeting off-target effects: endoplasmic reticulum stress and autophagy as effective strategies to enhance temozolomide treatment. OncoTargets and Therapy 12, pages 1857-1865.
Read now
Read now
Shibo Duan, Ming Li, Zhifeng Wang, Longlong Wang & Yongjie Liu. (2018) H19 induced by oxidative stress confers temozolomide resistance in human glioma cells via activating NF-κB signaling. OncoTargets and Therapy 11, pages 6395-6404.
Read now
Read now
Clara Di Vito, Stefania Elena Navone, Giovanni Marfia, Loubna Abdel Hadi, Maria Elisa Mancuso, Alessandro Pecci, Francesco Maria Crisà, Valeria Berno, Paolo Rampini, Rolando Campanella & Laura Riboni. (2017) Platelets from glioblastoma patients promote angiogenesis of tumor endothelial cells and exhibit increased VEGF content and release. Platelets 28:6, pages 585-594.
Read now
Read now
Liliana R. Oancea-Castillo, Carmen Klein, Amir Abdollahi, Klaus-Josef Weber, Anne Régnier-Vigouroux & Ivana Dokic. (2017) Comparative analysis of the effects of a sphingosine kinase inhibitor to temozolomide and radiation treatment on glioblastoma cell lines. Cancer Biology & Therapy 18:6, pages 400-406.
Read now
Read now
Danop Nanegrungsunk, Nattayaporn Apaijai, Chontida Yarana, Jirapas Sripetchwandee, Kriengsak Limpastan, Wanarak Watcharasaksilp, Tanat Vaniyapong, Nipon Chattipakorn & Siriporn C Chattipakorn. (2016) Bevacizumab is superior to Temozolomide in causing mitochondrial dysfunction in human brain tumors. Neurological Research 38:4, pages 285-293.
Read now
Read now
Articles from other publishers (34)
Kun Deng & Minghua Wu. (2023) Leucine-rich repeats containing 4 protein (LRRC4) in memory, psychoneurosis, and glioblastoma. Chinese Medical Journal 136:1, pages 4-12.
Crossref
Crossref
Anagha Acharekar, Ketaki Bachal, Pallavi Shirke, Rahul Thorat, Archisman Banerjee, Nilesh Gardi, Abhijit Majumder & Shilpee Dutt. (2023) Substrate stiffness regulates the recurrent glioblastoma cell morphology and aggressiveness. Matrix Biology 115, pages 107-127.
Crossref
Crossref
Lianxin Li, Zhihao Yang, Yinfei Zheng, Zhigang Chen, Xiaoyu Yue, Erbao Bian & Bing Zhao. (2022) Identification of an endoplasmic reticulum stress-related signature associated with clinical prognosis and immune therapy in glioma. BMC Neurology 22:1.
Crossref
Crossref
Shao-Wei Feng, Pei-Chi Chang, Hsuan-Yu Chen, Dueng-Yuan Hueng, Yao-Feng Li & Shih-Ming Huang. (2022) Exploring the Mechanism of Adjuvant Treatment of Glioblastoma Using Temozolomide and Metformin. International Journal of Molecular Sciences 23:15, pages 8171.
Crossref
Crossref
João Victor Roza Cruz, Carolina Batista, Bernardo de Holanda Afonso, Magna Suzana Alexandre-Moreira, Luiz Gustavo Dubois, Bruno Pontes, Vivaldo Moura Neto & Fabio de Almeida Mendes. (2022) Obstacles to Glioblastoma Treatment Two Decades after Temozolomide. Cancers 14:13, pages 3203.
Crossref
Crossref
Stella Sun, Karrie Kiang & Gilberto Leung. (2022) Chaperone protein P4HB predicts temozolomide response and prognosis in malignant glioma. Oncology Letters 24:2.
Crossref
Crossref
Jubo Wang, Yu Quan, Jian Lv, Shouping Gong & Pengyu Ren. (2022)
Inhibition of
FAM83D
displays antitumor effects in glioblastoma via down‐regulation of the
AKT
/Wnt/β‐catenin pathway
. Environmental Toxicology 37:6, pages 1343-1356.
Crossref
Crossref
Hanren Chen & Jian Wen. (2022) Iron oxide nanoparticles loaded with paclitaxel inhibits glioblastoma by enhancing autophagy-dependent ferroptosis pathway. European Journal of Pharmacology 921, pages 174860.
Crossref
Crossref
Yao-Min Li, Li-Hui Meng, Yan-Ru Hu, Tian-Tian Zhang, Zheng-Nan Su, Zhi-Yuan Ouyang, Wen-Chao Li, Jiang-Ling Wan & Qing-Zhi Wu. (2022) Suppression mechanisms on proliferation of glioma U251 cells by FePt nanoparticles through intracellular oxidative stress. Rare Metals 41:4, pages 1202-1209.
Crossref
Crossref
Fernanda Bueno Morrone, Pedro Vargas, Liliana Rockenbach & Thamiris Becker Scheffel. (2021) P2Y12 Purinergic Receptor and Brain Tumors: Implications on Glioma Microenvironment. Molecules 26:20, pages 6146.
Crossref
Crossref
Preantha Poonan, Clement Agoni, Mahmoud A. A. Ibrahim & Mahmoud E. S. Soliman. (2021) Glioma-Targeted Therapeutics: Computer-Aided Drug Design Prospective. The Protein Journal 40:5, pages 601-655.
Crossref
Crossref
Ana Laura V. Alves, Izabela N. F. Gomes, Adriana C. Carloni, Marcela N. Rosa, Luciane S. da Silva, Adriane F. Evangelista, Rui Manuel Reis & Viviane Aline O. Silva. (2021) Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives. Stem Cell Research & Therapy 12:1.
Crossref
Crossref
S. Daisy Precilla, Shreyas S. Kuduvalli & Anitha Thirugnanasambandhar Sivasubramanian. (2020) Disentangling the therapeutic tactics in GBM: From bench to bedside and beyond. Cell Biology International 45:1, pages 18-53.
Crossref
Crossref
Qiao-Li Lv, Li-Chong Wang, Dang-Chi Li, Qian-Xia Lin, Xiao-Li Shen, Hai-Yun Liu, Min Li, Yu-Long Ji, Chong-Zhen Qin & Shu-Hui Chen. (2020) Knockdown lncRNA DLEU1 Inhibits Gliomas Progression and Promotes Temozolomide Chemosensitivity by Regulating Autophagy. Frontiers in Pharmacology 11.
Crossref
Crossref
Xiaoqin Ma, Meixiang Yu, Chenxia Hao & Wanhua Yang. (2020) Shikonin induces tumor apoptosis in glioma cells via endoplasmic reticulum stress, and Bax/Bak mediated mitochondrial outer membrane permeability. Journal of Ethnopharmacology 263, pages 113059.
Crossref
Crossref
Beibei Zhai, Yue Li, Sudha Sravanti Kotapalli, Jeffrey Bacha, Dennis Brown, Anne Steinø & Mads Daugaard. (2020) Dianhydrogalactitol synergizes with topoisomerase poisons to overcome DNA repair activity in tumor cells. Cell Death & Disease 11:7.
Crossref
Crossref
Jianbo Feng, Yan Zhang, Xing Ren, Di Li, Haijuan Fu, Changhong Liu, Wen Zhou, Qing Liu, Qiang Liu & Minghua Wu. (2020) Leucine-rich repeat containing 4 act as an autophagy inhibitor that restores sensitivity of glioblastoma to temozolomide. Oncogene 39:23, pages 4551-4566.
Crossref
Crossref
Mohammad Norouzi. (2020) Gold Nanoparticles in Glioma Theranostics. Pharmacological Research 156, pages 104753.
Crossref
Crossref
Zhi-peng Wen, Wen-jing Zeng, Yan-hong Chen, He Li, Jie-ya Wang, Quan Cheng, Jing Yu, Hong-hao Zhou, Zheng-zheng Liu, Jian Xiao & Xiao-ping Chen. (2019) Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Crossref
Moumita Kundu, Subhayan Das, Dibakar Dhara & Mahitosh Mandal. (2019) Prospect of natural products in glioma: A novel avenue in glioma management. Phytotherapy Research 33:10, pages 2571-2584.
Crossref
Crossref
Jiancun Wang, Guancheng Hu & Xingyun Quan. (2019) Analysis of the factors affecting the prognosis of glioma patients. Open Medicine 14:1, pages 331-335.
Crossref
Crossref
Ming-Chung Lin, Yuan-Wen Lee, Yuan-Yun Tseng, Yung-Wei Lin, Jui-Tai Chen, Shing-Hwa Liu & Ruei-Ming Chen. (2019) Honokiol Induces Autophagic Apoptosis in Neuroblastoma Cells through a P53-Dependent Pathway. The American Journal of Chinese Medicine 47:04, pages 895-912.
Crossref
Crossref
Elzbieta Pawlowska, Joanna Szczepanska, Magdalena Szatkowska & Janusz Blasiak. (2018) An Interplay between Senescence, Apoptosis and Autophagy in Glioblastoma Multiforme—Role in Pathogenesis and Therapeutic Perspective. International Journal of Molecular Sciences 19:3, pages 889.
Crossref
Crossref
Shabierjiang JIAPAER, Takuya FURUTA, Shingo TANAKA, Tomohiro KITABAYASHI & Mitsutoshi NAKADA. (2018) Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma. Neurologia medico-chirurgica 58:10, pages 405-421.
Crossref
Crossref
Chunming Jiang, Fang Shen, Jianmin Du, Xiang Fang, Xiaoli Li, Jin Su, Xiaohua Wang, Xianmei Huang & Zhangli Liu. (2018) Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression. Biomedicine & Pharmacotherapy 97, pages 844-850.
Crossref
Crossref
Feng Jin, Guang-Kui Han, Hao Zhang, Ran Zhang, Gen-Hua Li, Song Feng, Xian-Yun Qin, Ling-Sheng Kong, Quan-Min Nie, Hua-Rong Li & Lei Zhao. (2017) Difference in the Inhibitory Effect of Temozolomide on TJ905 Glioma Cells and Stem Cells. Frontiers in Neurology 8.
Crossref
Crossref
Lin Shi, Hongyuan Li & Yang Zhan. (2017) All-trans retinoic acid enhances temozolomide-induced autophagy in human glioma cells U251 via targeting Keap1/Nrf2/ARE signaling pathway. Oncology Letters 14:3, pages 2709-2714.
Crossref
Crossref
Sean Mahase, Rachel N. Rattenni, Pieter Wesseling, William Leenders, Clarissa Baldotto, Rajan Jain & David Zagzag. (2017) Hypoxia-Mediated Mechanisms Associated with Antiangiogenic Treatment Resistance in Glioblastomas. The American Journal of Pathology 187:5, pages 940-953.
Crossref
Crossref
Bor-Chin Cheng, Jui-Tai Chen, Shun-Tai Yang, Chung-ching Chio, Shing-Hwa Liu & Ruei-Ming Chen. (2017) Cobalt chloride treatment induces autophagic apoptosis in human glioma cells via a p53-dependent pathway. International Journal of Oncology 50:3, pages 964-974.
Crossref
Crossref
Yuanliang Yan, Zhijie Xu, Shuang Dai, Long Qian, Lunquan Sun & Zhicheng Gong. (2016) Targeting autophagy to sensitive glioma to temozolomide treatment. Journal of Experimental & Clinical Cancer Research 35:1.
Crossref
Crossref
Jiahao Su, Meiqin Cai, Wensheng Li, Bo Hou, Haiyong He, Cong Ling, Tengchao Huang, Huijiao Liu & Ying Guo. (2016) Molecularly Targeted Drugs Plus Radiotherapy and Temozolomide Treatment for Newly Diagnosed Glioblastoma: A Meta-Analysis and Systematic Review. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 24:2, pages 117-128.
Crossref
Crossref
Monika Paul-Samojedny, Adam Pudełko, Małgorzata Kowalczyk, Anna Fila-Daniłow, Renata Suchanek-Raif, Paulina Borkowska & Jan Kowalski. (2016) Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells. BioDrugs 30:2, pages 129-144.
Crossref
Crossref
Michael Iv, Nicholas Telischak, Dan Feng, Samantha J Holdsworth, Kristen W Yeom & Heike E Daldrup-Link. (2015) Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors. Nanomedicine 10:6, pages 993-1018.
Crossref
Crossref
Eivind A. Segtnan, Søren Hess, Peter Grupe & Poul Flemming Høilund-Carlsen. (2015) 18F-Fluorodeoxyglucose PET/Computed Tomography for Primary Brain Tumors. PET Clinics 10:1, pages 59-73.
Crossref
Crossref